James Brophy

Has grant

Professor

McGill University

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor James Brophy is a faculty member at McGill University, Canada. His research focuses on cardiology, with recent articles addressing various aspects of cardiovascular health, including postoperative delirium prevention, heart failure hospitalization predictive factors, and the impact of COVID-19 on hypertension care. His work encompasses both clinical trials and systematic reviews, contributing significantly to the understanding of treatment approaches in acute coronary syndrome and atrial fibrillation.

Recent Grants

Grant: Close

Evaluative research in tertiary cardiology

Open Date: 2018-07-01

Close Date: 2023-06-01

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (2)

Emily McDonald

Associate professor of medicine

McGill University Health Centre

CANADA

View details

Miceline MESIDOR

Professeure adjointe

Institut national de la recherche scientifique

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Brophy

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (18)

A Protective Effect of Smoking on Repeat Revascularization

Perioperative dexmedetomidine for the prevention of postoperative delirium after cardiac surgery: a systematic review, Bayesian meta-analysis, and Bayesian re-analysis of the DECADE trial

Predicting death or readmission following heart failure hospitalisation: the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry

The 2025 Guideline Update Endorses Ticagrelor Monotherapy After ≥1 Month of DAPT Post-PCI in Patients With ACS

The Trials of Interpreting Clinical Trials—A Bayesian Perspective on Colchicine After an Acute Coronary Syndrome

Impact of the COVID-19 pandemic on primary care for hypertension in the UK: a population-based cohort study

Reply to Reiffel—Numbers Don’t Lie—But They Tell Only Part of the Story

Amiodarone vs Dronedarone for Atrial Fibrillation: A Retrospective Cohort Study

Marginal structural models with latent class growth analysis of treatment trajectories: Statins for primary prevention among older adults

Beta-Blockers, Digoxin, or Both Following an Incident Diagnosis of Atrial Fibrillation: A Prospective Cohort Study

Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population‐Based Cohort Study

Understanding Associations, Social Inequities, and Cardiovascular Risks

Developing a cross-validation tool for evaluating economic evidence in rapid literature reviews

Big Data, Big Expectations, and Big Judgements

Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study

Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Domperidone increases harmful cardiac events in Parkinson's disease: A Bayesian re-analysis of an observational study

Bayesian Analyses of Cardiovascular Trials—Bringing Added Value to the Table

Collaborators (2)

Emily McDonald

Miceline MESIDOR

Make your next move.